Particle  ||| S:0 E:9 ||| JJ
size  ||| S:9 E:14 ||| NN
of  ||| S:14 E:17 ||| IN
inhaled  ||| S:17 E:25 ||| JJ
corticosteroids ||| S:25 E:40 ||| NN
:  ||| S:40 E:42 ||| :
does  ||| S:42 E:47 ||| VBZ
it  ||| S:47 E:50 ||| PRP
matter ||| S:50 E:56 ||| VBP
?  ||| S:56 E:58 ||| .
A  ||| S:58 E:60 ||| DT
question  ||| S:60 E:69 ||| NN
with  ||| S:69 E:74 ||| IN
respect  ||| S:74 E:82 ||| NN
to  ||| S:82 E:85 ||| TO
asthma  ||| S:85 E:92 ||| VB
therapy  ||| S:92 E:100 ||| NN
revolves  ||| S:100 E:109 ||| VBZ
around  ||| S:109 E:116 ||| IN
the  ||| S:116 E:120 ||| DT
issue  ||| S:120 E:126 ||| NN
of  ||| S:126 E:129 ||| IN
whether  ||| S:129 E:137 ||| IN
better  ||| S:137 E:144 ||| JJR
efficacy  ||| S:144 E:153 ||| NN
occurs  ||| S:153 E:160 ||| VBZ
with  ||| S:160 E:165 ||| IN
an  ||| S:165 E:168 ||| DT
ultrafine-particle  ||| S:168 E:187 ||| JJ
inhaled  ||| S:187 E:195 ||| JJ
corticosteroid  ||| S:195 E:210 ||| NN
because  ||| S:210 E:218 ||| IN
of  ||| S:218 E:221 ||| IN
better  ||| S:221 E:228 ||| JJR
lung  ||| S:228 E:233 ||| NN
deposition  ||| S:233 E:244 ||| NN
into  ||| S:244 E:249 ||| IN
the  ||| S:249 E:253 ||| DT
distal  ||| S:253 E:260 ||| JJ
airways ||| S:260 E:267 ||| NN
.  ||| S:267 E:269 ||| .
This  ||| S:269 E:274 ||| DT
article  ||| S:274 E:282 ||| NN
reviews  ||| S:282 E:290 ||| VBZ
particle  ||| S:290 E:299 ||| JJ
size  ||| S:299 E:304 ||| NN
and  ||| S:304 E:308 ||| CC
delivery  ||| S:308 E:317 ||| NN
devices  ||| S:317 E:325 ||| NNS
of  ||| S:325 E:328 ||| IN
different  ||| S:328 E:338 ||| JJ
steroids ||| S:338 E:346 ||| NNS
,  ||| S:346 E:348 ||| ,
clinical  ||| S:348 E:357 ||| JJ
outcomes  ||| S:357 E:366 ||| NNS
of  ||| S:366 E:369 ||| IN
small-  ||| S:369 E:376 ||| FW
versus  ||| S:376 E:383 ||| FW
large-particle  ||| S:383 E:398 ||| FW
steroids ||| S:398 E:406 ||| FW
,  ||| S:406 E:408 ||| ,
and  ||| S:408 E:412 ||| CC
the  ||| S:412 E:416 ||| DT
issue  ||| S:416 E:422 ||| NN
of  ||| S:422 E:425 ||| IN
pharmacoeconomics ||| S:425 E:442 ||| NN
.  ||| S:442 E:444 ||| .
